Navigation Links
Cuff Repair Plate™ Receives Design and Utility Patents
Date:6/29/2012

Waxhaw, NC (PRWEB) June 29, 2012

Shoulder Options, a developer and manufacturer of orthopedic devices headquartered in Waxhaw, NC, announces that the U.S. Patent and Trademark Office (USPTO) has allowed both design and utility patents covering its Cuff Repair Plate™ (CRP) device.

“We are very pleased that the USPTO has determined that the concept is novel and worthy of both types of patents,” said inventor C. Scott Humphrey, MD. Dr. Humphrey is a practicing orthopaedic surgeon at the Humphrey Shoulder Clinic in Eagle, ID.

The CRP is a small, implantable device used for rotator cuff repair surgery, especially in cases of large tendon tears in the presence of osteopenia. Biomechanical testing results have shown that a repair with the CRP is up to 13 times stronger than a repair by other methods under conditions involving poor bone quality.

Dr. John Costouros, Assistant Professor of Orthopaedic Surgery and a Shoulder Specialist at Stanford University adds, “The management of rotator cuff disease is one of the most common problems that we treat as orthopaedic surgeons. Especially today, where our population is living longer and is interested in remaining more active, the CRP is a valuable tool that will enhance our ability to treat rotator cuff tears in patients with osteopenic bone.”

To learn more about Shoulder Options and the Cuff Repair Plate visit http://www.shoulderoptions.com.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9647692.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Miami Children’s Hospital Performs First Nerve Repair Surgery Using Avance® Nerve Graft Technology
2. Newtown Square Liberty to Donate 10 Percent of July Repairs to St. Jude Children’s Research Hospital
3. Facial defects shown to self-repair
4. Researchers Repair Damage Caused by Heart Attacks in Mice
5. Special Needs Spotlight: Former SFMTA Board Member Bruce Oka Receives Treatment with San Francisco Sedation Dentist Dr. David Blende
6. Clifford Saper, MD, PhD, receives Distinguished Scientist Award from the Sleep Research Society
7. Johns Hopkins African bioethics program receives 5-year continuation grant from NIH
8. Aging Brain Care model receives $7.8 million in CMS innovation funding
9. The W3 Project Receives Support from Doulton for Emergency Relief Efforts
10. High value health care collaborative receives $26 million health care innovation grant
11. Pediatric kidney expert receives Young Investigator Award from American Transplant Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: